Drugs from nature targeting inflammation: in discussion with Atanas Atanasov
MedChemNet discusses DNTI, an interdisciplinary network project with success in identifying novel drug candidates for inflammation, with Atanas Atanasov, one of the project’s collaborators.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>